Neil has over 20 year’s experience in the biotechnology industry covering both research and Business Development. Neil’s industrial experience started in R&D (UK Head of Research for Whatman Biosciences), before joining PA Consulting where he focused on business development and operational roles in the biotech sector. Neil then joined Antitope as VP Business Development. During his tenure at Antitope he was key to the year on year growth of the company and part of the team that steered the company through the acquisition by Polytherics. After acquisition, Neil was part of the executive management team that oversaw the rebranding as Abzena, listing on the London AIM market and the acquisition of two US companies.